EVGN icon

Evogene

16 hedge funds and large institutions have $10.8M invested in Evogene in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 1 closing their positions.

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
8
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
WRF
1
Waddell & Reed Financial
Kansas
$4.14M 2,757,203 -38,500 -1%
UBS Group
2
UBS Group
Switzerland
$2.08M 1,370,843 -41,483 -3%
Goldman Sachs
3
Goldman Sachs
New York
$1.13M 740,184 -27,000 -4%
SM
4
Senvest Management
New York
$630K 414,682
CI
5
Clal Insurance
Israel
$591K 899 -590,365 -100%
MCM
6
Moon Capital Management
New York
$556K 365,738
Bank of America
7
Bank of America
North Carolina
$494K 325,104
PF
8
Phoenix Financial
Israel
$397K 263,133
AIM
9
ARK Investment Management
Florida
$345K 227,211 +17,963 +9%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$335K 220,373 -938 -0.4%
MIH
11
Meitav Investment House
Israel
$30K 19,717 -52,134 -73%
Jane Street
12
Jane Street
New York
$19K 12,618 -23,125 -65%
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$15K 10,000
Citigroup
14
Citigroup
New York
$12K 7,976
Barclays
15
Barclays
United Kingdom
$1K 696
Citadel Advisors
16
Citadel Advisors
Florida
-19,375 Closed
Morgan Stanley
17
Morgan Stanley
New York
$0 52 -10,000 -99%
CFGS
18
Concourse Financial Group Securities
Alabama